AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2019
Jan 2, 2019
31676_dirs_2019-01-02_d999ecfd-ff29-4fc5-9a73-33f73bbeca85.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2018-12-31
Reporting Person: PRZYBYL ARTHUR (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-30 | Common Stock | G | 2180 | — | Disposed | 205076 | Direct |
Footnotes
F1: The Reporting Person gifted the shares. No reconsideration was paid for the shares.
More from ANI PHARMACEUTICALS INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Mar 3